Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment

Mesenchymal stem cells (MSCs) are promising cells to treat cartilage defects due to their chondrogenic differentiation potential. However, an inflammatory environment during differentiation, such as the presence of the cytokine TNFα, inhibits chondrogenesis and limits the clinical use of MSCs. On th...

Descripción completa

Detalles Bibliográficos
Autores principales: Voskamp, Chantal, Koevoet, Wendy J. L. M., Somoza, Rodrigo A., Caplan, Arnold I., Lefebvre, Véronique, van Osch, Gerjo J. V. M., Narcisi, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344141/
https://www.ncbi.nlm.nih.gov/pubmed/32714905
http://dx.doi.org/10.3389/fbioe.2020.00658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7344141/
https://www.ncbi.nlm.nih.gov/pubmed/32714905
http://dx.doi.org/10.3389/fbioe.2020.00658

Ejemplares similares